Povidone-Iodine
CAS 25655-41-8
Povidone-Iodine (CAS 25655-41-8) is a pharmaceutical compound with 0 bioactivity targets and 1,943 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Endophthalmitis | 384 | 1959.007 | 10014801 |
| Toxic anterior segment syndrome | 260 | 1469.926 | 10066366 |
| Hypopyon | 80 | 433.485 | 10021086 |
| Visual acuity reduced | 135 | 348.811 | 10047531 |
| Corneal oedema | 77 | 346.291 | 10011033 |
| Eye pain | 121 | 264.772 | 10015958 |
| Vitritis | 57 | 258.139 | 10047663 |
| Aqueous fibrin | 34 | 225.293 | 10054773 |
| Retinopathy of prematurity | 43 | 224.525 | 10038933 |
| Eye inflammation | 65 | 212.112 | 10015943 |
| Anterior chamber cell | 42 | 203.367 | 10053781 |
| Drug hypersensitivity | 221 | 191.43 | 10013700 |
| Vitreous floaters | 54 | 162.767 | 10047654 |
| Vision blurred | 122 | 154.566 | 10047513 |
| Anterior chamber fibrin | 23 | 137.517 | 10054774 |
| Ocular hyperaemia | 67 | 130.25 | 10030041 |
| Intraocular pressure increased | 47 | 124.829 | 10022806 |
| Non-infectious endophthalmitis | 25 | 120.017 | 10069093 |
| Blindness | 65 | 115.99 | 10005169 |
| Visual impairment | 95 | 111.87 | 10047571 |
| Tonsillar ulcer | 21 | 106.464 | 10050211 |
| Macular oedema | 35 | 101.689 | 10025415 |
| Punctate keratitis | 23 | 96.199 | 10037508 |
| Anaphylactic reaction | 79 | 92.277 | 10002198 |
| Blindness unilateral | 36 | 89.383 | 10005186 |
| Retinal haemorrhage | 34 | 84.207 | 10038867 |
| Lower respiratory tract infection viral | 21 | 84.003 | 10065188 |
| Bacterial endophthalmitis | 15 | 83.805 | 10084936 |
| Metamorphopsia | 22 | 82.089 | 10063341 |
| Vitreous haemorrhage | 27 | 80.569 | 10047655 |
| Eye irritation | 45 | 79.867 | 10015946 |
| Corneal epithelium defect | 18 | 78.419 | 10011010 |
| Off label use | 281 | 72.169 | 10053762 |
| Conjunctival oedema | 18 | 70.293 | 10010726 |
| Lip ulceration | 21 | 68.169 | 10024572 |
| Cataract nuclear | 18 | 67.279 | 10007759 |
| Vitreous detachment | 21 | 67.073 | 10047650 |
| Eye oedema | 19 | 61.753 | 10052139 |
| Anaphylactic shock | 42 | 60.371 | 10002199 |
| Inadequate aseptic technique in use of product | 11 | 60.17 | 10072608 |
| Procedural pain | 36 | 59.711 | 10064882 |
| Conjunctivitis | 38 | 59.203 | 10010741 |
| Suspected transmission of an infectious agent via product | 16 | 58.784 | 10072754 |
| Vitreous disorder | 12 | 58.06 | 10047651 |
| Post procedural discomfort | 15 | 57.671 | 10054126 |
| Corneal abrasion | 16 | 57.209 | 10010984 |
| Conjunctival hyperaemia | 21 | 56.053 | 10051625 |
| Parophthalmia | 12 | 55.779 | 10059407 |
| Foreign body sensation in eyes | 18 | 55.154 | 10051116 |
| Retinal pigment epithelial tear | 13 | 54.91 | 10062971 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| povidone-iodine | 8611 | SU | MTHSPL |
| POVIDONE-IODINE | 8611 | SU | MTHSPL |
| Povidone-Iodine | 8611 | SU | MTHSPL |
| Povidone-iodine | 8611 | SU | MTHSPL |
| povidone-iodine | 8611 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Povidone-Iodine used for in pharmaceutical contexts?
Povidone-Iodine (CAS 25655-41-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Povidone-Iodine?
Povidone-Iodine has 1,943 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Endophthalmitis, Toxic anterior segment syndrome, Hypopyon, Visual acuity reduced, Corneal oedema. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Povidone-Iodine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for PVP-Iodine with EU status "permitted".
What clinical phase is Povidone-Iodine in?
No phase 1-4 clinical development badge is rendered for Povidone-Iodine because the matched compound identifier rows do not contain a max-phase value.